Photrexa cross-linking kit 6ML
Ended Awarded Last action
- Contract number
- SPE2DR26FSGY3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,450
Award facts
- Contract value 100% obligated
- $8,450.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $8,450.43 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ML. The delivery order, issued December 1, 2025, with an ultimate completion date of December 22, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which was awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036.
The PPV-G GEN V represents a $30.3 billion Defense Logistics Agency acquisition strategy designed to establish multiple regional prime vendor contractors supplying a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities worldwide. Under this framework, DMS Pharmaceutical Group is authorized to fulfill firm fixed-price delivery orders for branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals. The contractor's established performance across numerous delivery orders and its specialized product portfolio position it as a critical supplier within the federal military medical pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FSGY3?
SPE2DR26FSGY3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FSGY3 worth?
The government has obligated $8,450 on SPE2DR26FSGY3.
Is contract SPE2DR26FSGY3 an order under another contract?
Yes. SPE2DR26FSGY3 is a delivery order under SPE2DR25D9305, an indefinite delivery contract.
Was contract SPE2DR26FSGY3 competed?
The extent of competition for SPE2DR26FSGY3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award